3.26.1 html 180 344 1 true 65 0 false 8 false false R1.htm 75000 - Document - Document and Entity Information Sheet http://catalystpharma.com/20260331/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 75010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://catalystpharma.com/20260331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 75020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://catalystpharma.com/20260331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 75030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) Sheet http://catalystpharma.com/20260331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) Statements 4 false false R5.htm 75040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Parenthetical) Sheet http://catalystpharma.com/20260331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossParenthetical CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Parenthetical) Statements 5 false false R6.htm 75050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://catalystpharma.com/20260331/taxonomy/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 75060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://catalystpharma.com/20260331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 8 false false R9.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 9 false false R10.htm 995457 - Disclosure - Organization and Description of Business Sheet http://catalystpharma.com/20260331/taxonomy/role/OrganizationAndDescriptionOfBusiness Organization and Description of Business Notes 10 false false R11.htm 995467 - Disclosure - Basis of Presentation and Significant Accounting Policies Sheet http://catalystpharma.com/20260331/taxonomy/role/BasisOfPresentationAndSignificantAccountingPolicies Basis of Presentation and Significant Accounting Policies Notes 11 false false R12.htm 995477 - Disclosure - Investments Sheet http://catalystpharma.com/20260331/taxonomy/role/Investments Investments Notes 12 false false R13.htm 995487 - Disclosure - Accumulated Other Comprehensive Income (Loss) Sheet http://catalystpharma.com/20260331/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLoss Accumulated Other Comprehensive Income (Loss) Notes 13 false false R14.htm 995497 - Disclosure - Inventory Sheet http://catalystpharma.com/20260331/taxonomy/role/DisclosureInventory1 Inventory Notes 14 false false R15.htm 995507 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://catalystpharma.com/20260331/taxonomy/role/PrepaidExpensesAndOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 15 false false R16.htm 995517 - Disclosure - Operating Leases Sheet http://catalystpharma.com/20260331/taxonomy/role/OperatingLeases Operating Leases Notes 16 false false R17.htm 995527 - Disclosure - Property and Equipment, Net Sheet http://catalystpharma.com/20260331/taxonomy/role/PropertyAndEquipmentNet Property and Equipment, Net Notes 17 false false R18.htm 995537 - Disclosure - License and Acquired Intangibles, Net Sheet http://catalystpharma.com/20260331/taxonomy/role/LicenseAndAcquiredIntangiblesNet License and Acquired Intangibles, Net Notes 18 false false R19.htm 995547 - Disclosure - Accrued Expenses and Other Liabilities Sheet http://catalystpharma.com/20260331/taxonomy/role/AccruedExpensesAndOtherLiabilities Accrued Expenses and Other Liabilities Notes 19 false false R20.htm 995557 - Disclosure - Collaborative and Licensing Arrangements Sheet http://catalystpharma.com/20260331/taxonomy/role/CollaborativeAndLicensingArrangements Collaborative and Licensing Arrangements Notes 20 false false R21.htm 995567 - Disclosure - Commitments and Contingencies Sheet http://catalystpharma.com/20260331/taxonomy/role/CommitmentsAndContingencies Commitments and Contingencies Notes 21 false false R22.htm 995577 - Disclosure - Agreements Sheet http://catalystpharma.com/20260331/taxonomy/role/Agreements Agreements Notes 22 false false R23.htm 995587 - Disclosure - Income Taxes Sheet http://catalystpharma.com/20260331/taxonomy/role/IncomeTaxes Income Taxes Notes 23 false false R24.htm 995597 - Disclosure - Stockholders' Equity Sheet http://catalystpharma.com/20260331/taxonomy/role/StockholdersEquity Stockholders' Equity Notes 24 false false R25.htm 995607 - Disclosure - Stock Compensation Sheet http://catalystpharma.com/20260331/taxonomy/role/StockCompensation Stock Compensation Notes 25 false false R26.htm 995617 - Disclosure - Subsequent Events Sheet http://catalystpharma.com/20260331/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 26 false false R27.htm 995627 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies) Sheet http://catalystpharma.com/20260331/taxonomy/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies Basis of Presentation and Significant Accounting Policies (Policies) Policies http://catalystpharma.com/20260331/taxonomy/role/BasisOfPresentationAndSignificantAccountingPolicies 27 false false R28.htm 995637 - Disclosure - Basis of Presentation and Significant Accounting Policies (Tables) Sheet http://catalystpharma.com/20260331/taxonomy/role/BasisOfPresentationAndSignificantAccountingPoliciesTables Basis of Presentation and Significant Accounting Policies (Tables) Tables http://catalystpharma.com/20260331/taxonomy/role/BasisOfPresentationAndSignificantAccountingPolicies 28 false false R29.htm 995647 - Disclosure - Investments (Tables) Sheet http://catalystpharma.com/20260331/taxonomy/role/InvestmentsTables Investments (Tables) Tables http://catalystpharma.com/20260331/taxonomy/role/Investments 29 false false R30.htm 995657 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables) Sheet http://catalystpharma.com/20260331/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossTables Accumulated Other Comprehensive Income (Loss) (Tables) Tables http://catalystpharma.com/20260331/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLoss 30 false false R31.htm 995667 - Disclosure - Inventory (Tables) Sheet http://catalystpharma.com/20260331/taxonomy/role/DisclosureInventoryTables Inventory (Tables) Tables http://catalystpharma.com/20260331/taxonomy/role/DisclosureInventory1 31 false false R32.htm 995677 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://catalystpharma.com/20260331/taxonomy/role/PrepaidExpensesAndOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://catalystpharma.com/20260331/taxonomy/role/PrepaidExpensesAndOtherCurrentAssets 32 false false R33.htm 995687 - Disclosure - Operating Leases (Tables) Sheet http://catalystpharma.com/20260331/taxonomy/role/OperatingLeasesTables Operating Leases (Tables) Tables http://catalystpharma.com/20260331/taxonomy/role/OperatingLeases 33 false false R34.htm 995697 - Disclosure - Property and Equipment, Net (Tables) Sheet http://catalystpharma.com/20260331/taxonomy/role/PropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://catalystpharma.com/20260331/taxonomy/role/PropertyAndEquipmentNet 34 false false R35.htm 995707 - Disclosure - License and Acquired Intangibles, Net (Tables) Sheet http://catalystpharma.com/20260331/taxonomy/role/LicenseAndAcquiredIntangiblesNetTables License and Acquired Intangibles, Net (Tables) Tables http://catalystpharma.com/20260331/taxonomy/role/LicenseAndAcquiredIntangiblesNet 35 false false R36.htm 995717 - Disclosure - Accrued Expenses and Other Liabilities (Tables) Sheet http://catalystpharma.com/20260331/taxonomy/role/AccruedExpensesAndOtherLiabilitiesTables Accrued Expenses and Other Liabilities (Tables) Tables http://catalystpharma.com/20260331/taxonomy/role/AccruedExpensesAndOtherLiabilities 36 false false R37.htm 995727 - Disclosure - Agreements (Tables) Sheet http://catalystpharma.com/20260331/taxonomy/role/AgreementsTables Agreements (Tables) Tables http://catalystpharma.com/20260331/taxonomy/role/Agreements 37 false false R38.htm 995737 - Disclosure - Stock Compensation (Tables) Sheet http://catalystpharma.com/20260331/taxonomy/role/StockCompensationTables Stock Compensation (Tables) Tables http://catalystpharma.com/20260331/taxonomy/role/StockCompensation 38 false false R39.htm 995747 - Disclosure - Organization and Description of Business - Additional Information (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/OrganizationAndDescriptionOfBusinessAdditionalInformationDetail Organization and Description of Business - Additional Information (Detail) Details 39 false false R40.htm 995757 - Disclosure - Basis of Presentation and Significant Accounting Policies - Additional Information (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/BasisOfPresentationAndSignificantAccountingPoliciesAdditionalInformationDetail Basis of Presentation and Significant Accounting Policies - Additional Information (Detail) Details 40 false false R41.htm 995767 - Disclosure - Basis of Presentation and Significant Accounting Policies - Fair Value Measurement Specific to Assets or Liability (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/BasisOfPresentationAndSignificantAccountingPoliciesFairValueMeasurementSpecificToAssetsOrLiabilityDetail Basis of Presentation and Significant Accounting Policies - Fair Value Measurement Specific to Assets or Liability (Detail) Details 41 false false R42.htm 995777 - Disclosure - Basis of Presentation and Significant Accounting Policies - Summary of Disaggregated Product Revenue (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/BasisOfPresentationAndSignificantAccountingPoliciesSummaryOfDisaggregatedProductRevenueDetail Basis of Presentation and Significant Accounting Policies - Summary of Disaggregated Product Revenue (Detail) Details 42 false false R43.htm 995797 - Disclosure - Basis of Presentation and Significant Accounting Policies - Summary of Percentage of the Company's Total Net Product Revenue (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/BasisOfPresentationAndSignificantAccountingPoliciesSummaryOfPercentageOfTheCompanySTotalNetProductRevenueDetail Basis of Presentation and Significant Accounting Policies - Summary of Percentage of the Company's Total Net Product Revenue (Detail) Details 43 false false R44.htm 995807 - Disclosure - Basis of Presentation and Significant Accounting Policies - Schedule Of Reconcile Basic And Dilutive Weighted Average Common Shares (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/BasisOfPresentationAndSignificantAccountingPoliciesScheduleOfReconcileBasicAndDilutiveWeightedAverageCommonSharesDetail Basis of Presentation and Significant Accounting Policies - Schedule Of Reconcile Basic And Dilutive Weighted Average Common Shares (Detail) Details 44 false false R45.htm 995817 - Disclosure - Basis of Presentation and Significant Accounting Policies - Schedule of Significant Segment Expenses of Stock-based Compensation (Details) Sheet http://catalystpharma.com/20260331/taxonomy/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesScheduleOfSignificantSegmentExpensesOfStockbasedCompensationDetails Basis of Presentation and Significant Accounting Policies - Schedule of Significant Segment Expenses of Stock-based Compensation (Details) Details 45 false false R46.htm 995827 - Disclosure - Investments - Summary of Available-for-Sale Investments (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/DisclosureInvestmentsSummaryOfAvailableforsaleInvestmentsDetail Investments - Summary of Available-for-Sale Investments (Detail) Details 46 false false R47.htm 995837 - Disclosure - Investments - Additional Information (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/InvestmentsAdditionalInformationDetail Investments - Additional Information (Detail) Details 47 false false R48.htm 995847 - Disclosure - Investments - Estimated Fair Values of Available for Sale Securities (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/DisclosureInvestmentsEstimatedFairValuesOfAvailableForSaleSecuritiesDetail Investments - Estimated Fair Values of Available for Sale Securities (Detail) Details 48 false false R49.htm 995857 - Disclosure - Investments - Summary Of Net Gains And Losses On Equity Securities (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/InvestmentsSummaryOfNetGainsAndLossesOnEquitySecuritiesDetail Investments - Summary Of Net Gains And Losses On Equity Securities (Detail) Details 49 false false R50.htm 995867 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Summary of Reclassifications out of Accumulated Other Comprehensive Income (Loss) (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfReclassificationsOutOfAccumulatedOtherComprehensiveIncomeLossDetail Accumulated Other Comprehensive Income (Loss) - Summary of Reclassifications out of Accumulated Other Comprehensive Income (Loss) (Detail) Details http://catalystpharma.com/20260331/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossTables 50 false false R51.htm 995877 - Disclosure - Inventory - Summary of current inventory (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/DisclosureInventorySummaryOfCurrentInventoryDetail Inventory - Summary of current inventory (Detail) Details 51 false false R52.htm 995887 - Disclosure - Inventory - Additional Information (Details) Sheet http://catalystpharma.com/20260331/taxonomy/role/DisclosureInventoryAdditionalInformationDetails Inventory - Additional Information (Details) Details 52 false false R53.htm 995897 - Disclosure - Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/PrepaidExpensesAndOtherCurrentAssetsPrepaidExpensesAndOtherCurrentAssetsDetail Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Detail) Details 53 false false R54.htm 995907 - Disclosure - Operating Leases - Additional Information (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/DisclosureOperatingLeasesAdditionalInformationDetail Operating Leases - Additional Information (Detail) Details 54 false false R55.htm 995917 - Disclosure - Operating Leases - Operating Leases (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/OperatingLeasesOperatingLeasesDetail Operating Leases - Operating Leases (Detail) Details 55 false false R56.htm 995927 - Disclosure - Operating Leases - Schedule of Supplemental Cash Flow Information Related To Lease (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/OperatingLeasesScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetail Operating Leases - Schedule of Supplemental Cash Flow Information Related To Lease (Detail) Details 56 false false R57.htm 995937 - Disclosure - Operating Leases - Schedule of Supplemental Balance Sheet related To Lease (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/OperatingLeasesScheduleOfSupplementalBalanceSheetRelatedToLeaseDetail Operating Leases - Schedule of Supplemental Balance Sheet related To Lease (Detail) Details 57 false false R58.htm 995947 - Disclosure - Operating Leases - Lessee, Operating Lease, Liability, Maturity (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/OperatingLeasesLesseeOperatingLeaseLiabilityMaturityDetail Operating Leases - Lessee, Operating Lease, Liability, Maturity (Detail) Details 58 false false R59.htm 995967 - Disclosure - Property and Equipment, Net - Property and Equipment, Net (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/PropertyAndEquipmentNetPropertyAndEquipmentNetDetail Property and Equipment, Net - Property and Equipment, Net (Detail) Details 59 false false R60.htm 995977 - Disclosure - License and Acquired Intangibles, Net - Schedule of Finite Lived Intangible Assets (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/LicenseAndAcquiredIntangiblesNetScheduleOfFiniteLivedIntangibleAssetsDetail License and Acquired Intangibles, Net - Schedule of Finite Lived Intangible Assets (Detail) Details 60 false false R61.htm 995987 - Disclosure - License and Acquired Intangibles, Net - Additional Information (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/LicenseAndAcquiredIntangiblesNetAdditionalInformationDetail License and Acquired Intangibles, Net - Additional Information (Detail) Details 61 false false R62.htm 995997 - Disclosure - License and Acquired Intangibles, Net - Schedule of Finite-Lived, Future Amortization Expense (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/LicenseAndAcquiredIntangiblesNetScheduleOfFiniteLivedFutureAmortizationExpenseDetail License and Acquired Intangibles, Net - Schedule of Finite-Lived, Future Amortization Expense (Detail) Details 62 false false R63.htm 996007 - Disclosure - Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/AccruedExpensesAndOtherLiabilitiesScheduleOfAccruedExpensesAndOtherLiabilitiesDetail Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Detail) Details 63 false false R64.htm 996017 - Disclosure - Collaborative and Licensing Arrangements - Additional Information (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/CollaborativeAndLicensingArrangementsAdditionalInformationDetail Collaborative and Licensing Arrangements - Additional Information (Detail) Details 64 false false R65.htm 996027 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 65 false false R66.htm 996037 - Disclosure - Agreements - Additional Information (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/AgreementsAdditionalInformationDetail Agreements - Additional Information (Detail) Details 66 false false R67.htm 996047 - Disclosure - Agreements - Schedule Of Total Purchase Price Was Allocated To The Acquired Assets Based On Their Relative Fair Values (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/AgreementsScheduleOfTotalPurchasePriceWasAllocatedToTheAcquiredAssetsBasedOnTheirRelativeFairValuesDetail Agreements - Schedule Of Total Purchase Price Was Allocated To The Acquired Assets Based On Their Relative Fair Values (Detail) Details 67 false false R68.htm 996057 - Disclosure - Agreements - Summary of Aggregate Amount Paid for the Assets Acquired (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/AgreementsSummaryOfAggregateAmountPaidForTheAssetsAcquiredDetail Agreements - Summary of Aggregate Amount Paid for the Assets Acquired (Detail) Details 68 false false R69.htm 996067 - Disclosure - Agreements - Summary of Aggregate Amount Paid for the Assets Acquired (Parenthetical) (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/AgreementsSummaryOfAggregateAmountPaidForTheAssetsAcquiredParentheticalDetail Agreements - Summary of Aggregate Amount Paid for the Assets Acquired (Parenthetical) (Detail) Details 69 false false R70.htm 996077 - Disclosure - Agreements - Summary of Total Purchase Price Allocated to Acquired Assets (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/AgreementsSummaryOfTotalPurchasePriceAllocatedToAcquiredAssetsDetail Agreements - Summary of Total Purchase Price Allocated to Acquired Assets (Detail) Details 70 false false R71.htm 996087 - Disclosure - Agreements - Summary of aggregate amount paid for the assets (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/AgreementsSummaryOfAggregateAmountPaidForTheAssetsDetail Agreements - Summary of aggregate amount paid for the assets (Detail) Details 71 false false R72.htm 996097 - Disclosure - Agreements - Summary of total purchase price allocated (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/AgreementsSummaryOfTotalPurchasePriceAllocatedDetail Agreements - Summary of total purchase price allocated (Detail) Details 72 false false R73.htm 996107 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/IncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 73 false false R74.htm 996117 - Disclosure - Stockholders' Equity (Preferred Stock and Common Stock) - Additional Information (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/StockholdersEquityPreferredStockAndCommonStockAdditionalInformationDetail Stockholders' Equity (Preferred Stock and Common Stock) - Additional Information (Detail) Details http://catalystpharma.com/20260331/taxonomy/role/StockholdersEquity 74 false false R75.htm 996127 - Disclosure - Stockholders' Equity ( Share Repurchases ) - Additional Information (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/StockholdersEquityShareRepurchasesAdditionalInformationDetail Stockholders' Equity ( Share Repurchases ) - Additional Information (Detail) Details http://catalystpharma.com/20260331/taxonomy/role/StockholdersEquity 75 false false R76.htm 996147 - Disclosure - Stockholders' Equity (2023 Shelf Registration Statement) - Additional Information (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/StockholdersEquity2023ShelfRegistrationStatementAdditionalInformationDetail Stockholders' Equity (2023 Shelf Registration Statement) - Additional Information (Detail) Details http://catalystpharma.com/20260331/taxonomy/role/StockholdersEquity 76 false false R77.htm 996157 - Disclosure - Stock Compensation - Stock-Based Compensation Expense (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/StockCompensationStockBasedCompensationExpenseDetail Stock Compensation - Stock-Based Compensation Expense (Detail) Details 77 false false R78.htm 996167 - Disclosure - Stock Compensation - Additional Information (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/StockCompensationAdditionalInformationDetail Stock Compensation - Additional Information (Detail) Details 78 false false R79.htm 996177 - Disclosure - Subsequent Events - Additional Information (Detail) Sheet http://catalystpharma.com/20260331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail Subsequent Events - Additional Information (Detail) Details 79 false false All Reports Book All Reports cprx-20260331.htm cprx-20260331.xsd http://fasb.org/srt/2025 http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 false false